Cargando…
Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
Autores principales: | Shehadeh, Naim, Raz, Itamar, Nakhleh, Afif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103874/ https://www.ncbi.nlm.nih.gov/pubmed/30134893 http://dx.doi.org/10.1186/s12933-018-0760-6 |
Ejemplares similares
-
In the Limelight: Photoreceptors in Cyanobacteria
por: Bhaya, Devaki
Publicado: (2016) -
Interactions between antihyperglycemic drugs and the renin-angiotensin system: Putative roles in COVID-19. A mini-review
por: Nakhleh, Afif, et al.
Publicado: (2020) -
Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention
por: Nakhleh, Afif, et al.
Publicado: (2021) -
Cell morphologies in the nervous system: Glia steal the limelight
por: Ascoli, Giorgio A.
Publicado: (2022) -
Paradigm Shift or Shifting Paradigm for Type 1 Diabetes
por: Nakayama, Maki, et al.
Publicado: (2012)